# Biophytis SA (BPTS)

Source: https://www.quantisnow.com/company/BPTS
Generated: 2026-11-08T15:21:11.479Z

- Ticker: BPTS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- Website: biophytis.com

## About

Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases and the treatment of severe respiratory failure in patients suffering from COVID-19. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD). Its second drug candidate, Macuneos (BIO201), is an orally administered small molecule in development for the treatment of retinal diseases, including dry ager elated macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is based in Paris, France.

## Latest BPTS news and filings

- 2024-09-30 21:01 UTC [Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities](https://www.quantisnow.com/insight/biophytis-publishes-first-half-financial-results-and-provides-an-update-on-5708950)
- 2024-07-22 06:30 UTC [Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in Asia](https://www.quantisnow.com/insight/biophytis-deploys-its-partnership-strategy-and-signs-two-contracts-with-5618397)
- 2024-07-11 06:40 UTC [Biophytis Obtains IND Approval from the FDA to Start its Phase 2 OBA Study in Obesity](https://www.quantisnow.com/insight/biophytis-obtains-ind-approval-from-the-fda-to-start-its-5602874)
- 2024-07-01 05:20 UTC [Biophytis Presented its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris](https://www.quantisnow.com/insight/biophytis-presented-its-phase-2-3-cova-study-results-in-severe-5584792)
- 2024-06-20 05:20 UTC [Biophytis grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million](https://www.quantisnow.com/insight/biophytis-grants-blanver-exclusive-rights-to-bio101-in-latin-america-5566648)
- 2024-06-19 23:50 UTC [Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business Activities](https://www.quantisnow.com/insight/biophytis-extends-its-contract-with-atlas-to-secure-financing-for-5566636)
- 2024-06-12 08:25 UTC [Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by its Service Provider Seqens](https://www.quantisnow.com/insight/biophytis-announces-the-successful-industrial-transfer-of-bio101-20-hydroxyecdysone-production-5552357)
- 2024-06-10 06:40 UTC [Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity](https://www.quantisnow.com/insight/biophytis-announces-filing-of-an-ind-application-with-the-us-5546812)
- 2024-06-07 06:00 UTC [Combined General Meeting of June 24, 2024](https://www.quantisnow.com/insight/combined-general-meeting-of-june-24-2024-5543669)
- 2024-05-14 14:28 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biophytis SA](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biophytis-sa-5488066)
- 2024-05-14 05:20 UTC [Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity](https://www.quantisnow.com/insight/biophytis-announces-the-design-of-its-phase-2-oba-clinical-5486747)
- 2024-04-29 16:47 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biophytis SA](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biophytis-sa-5440456)
- 2024-04-29 13:12 UTC [Market Chatter] [Biophytis Is Deploying Its Partnership Strategy In Obesity](https://www.quantisnow.com/insight/biophytis-is-deploying-its-partnership-strategy-in-obesity-5439879)
- 2024-04-29 13:00 UTC [Biophytis is Deploying its Partnership Strategy in Obesity](https://www.quantisnow.com/insight/biophytis-is-deploying-its-partnership-strategy-in-obesity-5439842)
- 2024-04-25 17:57 UTC [Market Insight] [Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-caterpillar-shares-are-trading-lower-by-around-7-here-5433139)
- 2024-04-25 14:28 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biophytis SA](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biophytis-sa-5432598)
- 2024-04-25 10:12 UTC [Market Insight] [Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-teradyne-shares-are-trading-higher-by-over-8-here-5431164)
- 2024-04-24 21:30 UTC [Biophytis Announces Transfer of ADSs to OTC Market](https://www.quantisnow.com/insight/biophytis-announces-transfer-of-adss-to-otc-market-5430705)
- 2024-04-19 15:28 UTC [Market Chatter] [Biophytis shares are trading lower after the company announced that it will change the ratio of its American Depositary Shares From 100 to 4,000.](https://www.quantisnow.com/insight/biophytis-shares-are-trading-lower-after-the-company-announced-that-5420569)
- 2024-04-19 15:16 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biophytis SA](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biophytis-sa-5420560)
- 2024-04-19 06:48 UTC [Market Chatter] [Biophytis Announces ADR Ratio Change: From 100 To 4,000 Shares Per ADS, Effective April 23](https://www.quantisnow.com/insight/biophytis-announces-adr-ratio-change-from-100-to-4000-shares-5419655)
- 2024-04-19 05:20 UTC [Biophytis Announces Ratio Change Under its American Depositary Receipt ("ADR") Program](https://www.quantisnow.com/insight/biophytis-announces-ratio-change-under-its-american-depositary-receipt-adr-5419633)
- 2024-04-18 19:27 UTC [Market Chatter] [Biophytis shares are trading higher. The company announced the formation of a new Scientific Advisory Board to support the advancement of its phase 2 OBA clinical study in obesity.](https://www.quantisnow.com/insight/biophytis-shares-are-trading-higher-the-company-announced-the-formation-5418703)
- 2024-04-18 14:08 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biophytis SA](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biophytis-sa-5418055)
- 2024-04-18 07:01 UTC [Market Chatter] [Biophytis Plans To File IND With FDA For Phase 2 OBA Clinical Study In Obesity, Backed By New Scientific Advisory Board](https://www.quantisnow.com/insight/biophytis-plans-to-file-ind-with-fda-for-phase-2-5416982)
- 2024-04-18 05:20 UTC [Leadership Update] [Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity](https://www.quantisnow.com/insight/biophytis-announces-new-scientific-advisory-board-for-its-phase-2-5416961)
- 2024-04-15 14:14 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biophytis SA](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biophytis-sa-5410032)
- 2024-04-15 09:45 UTC [Market Insight] [Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-medical-properties-trust-shares-are-trading-higher-by-around-5409075)
- 2024-04-10 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-after-market-session-5403753)
- 2024-04-10 18:07 UTC [Market Insight] [Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-ascent-solar-technologies-shares-are-trading-lower-by-around-5403168)
- 2024-04-10 16:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-intraday-session-5402929)
- 2024-04-10 12:12 UTC [Market Insight] [Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-pricesmart-shares-are-trading-higher-by-around-5-here-5402152)
- 2024-04-10 12:09 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-pre-market-session-5402140)
- 2024-04-09 17:12 UTC [Market Insight] [Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-tilray-brands-shares-are-trading-lower-by-around-22-5400291)
- 2024-04-09 16:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biophytis SA](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biophytis-sa-5400204)
- 2024-04-09 16:05 UTC [Market Insight] [Dow Dips 150 Points; Laser Photonics Shares Spike Higher](https://www.quantisnow.com/insight/dow-dips-150-points-laser-photonics-shares-spike-higher-5400166)
- 2024-04-09 14:46 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biophytis SA](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biophytis-sa-5400020)
- 2024-04-09 14:06 UTC [Market Insight] [Why Is Penny Stock Biophytis Trading Higher On Tuesday?](https://www.quantisnow.com/insight/why-is-penny-stock-biophytis-trading-higher-on-tuesday-5399944)
- 2024-04-09 12:35 UTC [Market Chatter] [Biophytis shares are trading higher after the company reported a year-over-year increase in FY23 EPS results.](https://www.quantisnow.com/insight/biophytis-shares-are-trading-higher-after-the-company-reported-a-5399578)
- 2024-04-09 12:34 UTC [Market Chatter] [CORRECTION: Biophytis shares are trading higher after the company reported a year-over-year increase in FY23 EPS results.](https://www.quantisnow.com/insight/correction-biophytis-shares-are-trading-higher-after-the-company-reported-5399575)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BPTS
- Earnings history: https://www.quantisnow.com/earnings/BPTS
- Dividend history: https://www.quantisnow.com/dividends/BPTS
- Insider transactions: https://www.quantisnow.com/insiders/BPTS
- Options chain: https://www.quantisnow.com/options/BPTS
- SEC 8-K filings only: https://www.quantisnow.com/company/BPTS/8-k
- RSS and alerts for BPTS: https://www.quantisnow.com/docs/rss-feeds.md